Travere Therapeutics (TVTX) Receivables - Net (2014 - 2026)
Travere Therapeutics' Receivables - Net was $80.64 million in Q2 2026, up 108.3% from $38.72 million a year earlier but down 7.6% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Receivables - Net (2014 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Travere Therapeutics came in at $80.13 million, up 195.5% from FY2024.
- Receivables - Net has now increased for four consecutive years, with a five-year compound annual growth rate of 38.1% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $27.12 million in FY2024 (+27.9%), $21.2 million in FY2023 (+27.4%), $16.65 million in FY2022 (+4.6%) and $15.91 million in FY2021 (-0.1%).
- Quarterly Receivables - Net has moved between $12.7 million (Q3 2022) and $87.3 million (Q1 2026) over five years.
- Compared with a year earlier, Receivables - Net has increased for 15 straight quarters, with growth averaging 112.1% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2025 (growth of 229.4%); the worst was Q3 2021 (a decline of 10.8%).
- Per Business Quant data, TVTX's Receivables - Net in the three quarters before Q2 2026 was $87.3 million (Q1 2026), $80.13 million (Q4 2025) and $83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.64 Mn |
| Mar 31, 2026 | 87.30 Mn |
| Dec 31, 2025 | 80.13 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 38.72 Mn |
| Mar 31, 2025 | 34.40 Mn |
| Dec 31, 2024 | 27.12 Mn |
| Sep 30, 2024 | 25.20 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Mar 31, 2024 | 22.73 Mn |
| Dec 31, 2023 | 21.18 Mn |
| Sep 30, 2023 | 14.60 Mn |
| Jun 30, 2023 | 20.40 Mn |
| Mar 31, 2023 | 21.54 Mn |
| Dec 31, 2022 | 16.65 Mn |
| Sep 30, 2022 | 12.70 Mn |
| Jun 30, 2022 | 16.70 Mn |
| Mar 31, 2022 | 14.70 Mn |
| Dec 31, 2021 | 15.91 Mn |
| Sep 30, 2021 | 13.40 Mn |
API Access
Travere Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();